Concepedia

Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway

Xue Han, Chuanhua Ding, Guangdong Zhang, Ruiyan Pan, Yongping Liu, Na Huang, Ningning Hou, Fang Han, Wenjie Xu, Xiaodong Sun

Biochemical and Biophysical Research Communications · 2020 · 62 citations · 12 references

DOI

Concepts

References

12

Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has A Direct Role in Decreasing Hepatic Steatosis in Vitro by Modulating Elements of the Insulin Signaling Pathway

Nitika Gupta, Jamie E. Mells, Richard M. Dunham et al. · Hepatology · 2010 · 516 citations · Full text

, , +17

Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage

Soo Han Bae, Su Haeng Sung, Sue Young Oh et al. · Cell Metabolism · 2012 · 489 citations · Full text

, , +16

Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis

Gianluca Svegliati‐Baroni, S. Saccomanno, C. Rychlicki et al. · Liver International · 2011 · 398 citations · Full text

, , +17

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase

Shani Ben‐Shlomo, Isabel Zvibel, Mati Shnell et al. · Journal of Hepatology · 2010 · 316 citations

, , +13

Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy

Xinyang Yu, Ming Hao, Yu Liu et al. · European Journal of Pharmacology · 2019 · 189 citations

, , +16